MECHANISM OF ACTION
Targeted binding to a specific epitope induces distinct antitumor activity1-3
Directly destroys
myeloma cells through apoptosis
without the need for crosslinking
inhibits
CD38 enzymatic activity through
suppression of the CD38 ectoenzyme
triggers
cancer cell death through tumor cell
targeting, including ADCC, ADCP,
and CDC
Enhances
immune cell function through NK cell activation and a decrease in immunosuppressors
